{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/INO/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T09:52:13.448Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11178,"canonical_name":"INOVIO PHARMACEUTICALS, INC.","cik":"0001055726","uei":null,"lei":null,"duns":null,"ticker":"INO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":38,"court":1},"count":39,"timeline":[{"ts":"2026-07-10","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — INOVIO PHARMACEUTICALS, INC. — 2026-07-10","url_slug":"/sec/cik-0001055726/effect/9999999995-26-002261","accession_number":"9999999995-26-002261","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"S-3","title":"S-3 — INOVIO PHARMACEUTICALS, INC. — 2026-07-02","url_slug":"/sec/cik-0001055726/s-3/0001193125-26-294457","accession_number":"0001193125-26-294457","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001669080-26-000003","accession_number":"0001669080-26-000003","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001741836-26-000005","accession_number":"0001741836-26-000005","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001770390-26-000005","accession_number":"0001770390-26-000005","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001771423-26-000001","accession_number":"0001771423-26-000001","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001771498-26-000005","accession_number":"0001771498-26-000005","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001936799-26-000006","accession_number":"0001936799-26-000006","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001181186-26-000002","accession_number":"0001181186-26-000002","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001259780-26-000006","accession_number":"0001259780-26-000006","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001273306-26-000001","accession_number":"0001273306-26-000001","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001278219-26-000001","accession_number":"0001278219-26-000001","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-21","url_slug":"/sec/cik-0001055726/4/0001587788-26-000002","accession_number":"0001587788-26-000002","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"8-K","title":"8-K — INOVIO PHARMACEUTICALS, INC. — 2026-05-20","url_slug":"/sec/cik-0001055726/8-k/0001193125-26-232524","accession_number":"0001193125-26-232524","importance":35},{"ts":"2026-05-20","kind":"sec.insider.f","reporter":"Shea Jacqueline Elizabeth","title":"Chief Executive Officer","shares":12306,"price_per_share":1.23,"usd_value":15136,"security_title":"Common Stock","importance":15.01513638},{"ts":"2026-05-20","kind":"sec.insider.f","reporter":"KIES PETER","title":"CFO","shares":4688,"price_per_share":1.23,"usd_value":5766,"security_title":"Common Stock","importance":15.00576624},{"ts":"2026-05-20","kind":"sec.insider.f","reporter":"Sumner Michael John","title":"Chief Medical Officer","shares":2693,"price_per_share":1.23,"usd_value":3312,"security_title":"Common Stock","importance":15.00331239},{"ts":"2026-05-20","kind":"sec.insider.f","reporter":"Humeau Laurent","title":"Chief Scientific Officer","shares":2163,"price_per_share":1.23,"usd_value":2660,"security_title":"Common Stock","importance":15.00266049},{"ts":"2026-05-20","kind":"sec.insider.m","reporter":"Humeau Laurent","title":"Chief Scientific Officer","shares":6027,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-20","kind":"sec.insider.m","reporter":"Shea Jacqueline Elizabeth","title":"Chief Executive Officer","shares":28296,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-20","kind":"sec.insider.m","reporter":"Sumner Michael John","title":"Chief Medical Officer","shares":9450,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-20","kind":"sec.insider.m","reporter":"KIES PETER","title":"CFO","shares":8700,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-18","url_slug":"/sec/cik-0001055726/4/0001259780-26-000005","accession_number":"0001259780-26-000005","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-18","url_slug":"/sec/cik-0001055726/4/0001770390-26-000004","accession_number":"0001770390-26-000004","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-18","url_slug":"/sec/cik-0001055726/4/0001771498-26-000004","accession_number":"0001771498-26-000004","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — INOVIO PHARMACEUTICALS, INC. — 2026-05-18","url_slug":"/sec/cik-0001055726/4/0001936799-26-000005","accession_number":"0001936799-26-000005","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — INOVIO PHARMACEUTICALS, INC. — 2026-05-15","url_slug":"/sec/cik-0001055726/schedule-13g-a/0000919574-26-003181","accession_number":"0000919574-26-003181","importance":30},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Shea Jacqueline Elizabeth","title":"Chief Executive Officer","shares":7717,"price_per_share":1.3,"usd_value":10032,"security_title":"Common Stock","importance":15.0100321},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"KIES PETER","title":"CFO","shares":2571,"price_per_share":1.3,"usd_value":3342,"security_title":"Common Stock","importance":15.0033423},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Humeau Laurent","title":"Chief Scientific Officer","shares":1712,"price_per_share":1.3,"usd_value":2226,"security_title":"Common Stock","importance":15.0022256},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Sumner Michael John","title":"Chief Medical Officer","shares":680,"price_per_share":1.3,"usd_value":884,"security_title":"Common Stock","importance":15.000884},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"KIES PETER","title":"CFO","shares":4771,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Humeau Laurent","title":"Chief Scientific Officer","shares":4771,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Shea Jacqueline Elizabeth","title":"Chief Executive Officer","shares":17744,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Sumner Michael John","title":"Chief Medical Officer","shares":2385,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — INOVIO PHARMACEUTICALS, INC. — 2026-05-13","url_slug":"/sec/cik-0001055726/10-q/0001055726-26-000018","accession_number":"0001055726-26-000018","importance":45},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — INOVIO PHARMACEUTICALS, INC. — 2026-05-13","url_slug":"/sec/cik-0001055726/8-k/0001055726-26-000019","accession_number":"0001055726-26-000019","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — INOVIO PHARMACEUTICALS, INC. — 2026-05-13","url_slug":"/sec/cik-0001055726/schedule-13g-a/0000919574-26-002915","accession_number":"0000919574-26-002915","importance":30},{"ts":"2026-05-01","kind":"court.docket","reporter":"paed","title":"Panes v. Shea","security_title":"850 Other Statutes: Securities/Commodities","excerpt":"15:78m(a) Securities Exchange Act","accession_number":"2:26-cv-02940","product_type":"John R. Padova","importance":45}]}